News | December 26, 2023
BioVaxys executes LoI for major Immunotherapeutics technology acquisition
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Leading USA based genetic testing brand officially enters the Indian market
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Lokavant provides clinical trial intelligence
Dr. Singh proposes upskilling medicos with AI, Quantum and other newer technologies to meet the changing requirements of patient care
Subscribe To Our Newsletter & Stay Updated
